)
)
Oyster Point Pharma Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Oyster Point Pharma Inc
Access all reports
Oyster Point Pharma, Inc. is a biopharmaceutical company focused on developing therapies to address ophthalmic diseases. The company's primary area of focus is the treatment of dry eye disease and other ocular surface conditions. Oyster Point leverages its expertise in neuroscience and ophthalmology to develop innovative therapeutic solutions that aim to improve eye health and patient quality of life. The company serves the healthcare sector, specifically targeting the ophthalmology field with products designed to meet unmet medical needs in eye care. The company is headquartered in Princeton, New Jersey, and its shares are listed on the NASDAQ.
Latest articles
)
James Quincey: Coca-Cola Chairman and CEO
James Quincey has dedicated nearly three decades to The Coca-Cola Company, rising through the ranks to become CEO and Chairman of the company.
11 Mar 2025
)
PepsiCo: From Pepsi and Gatorade to Doritos and Lay's
PepsiCo has grown from a soda company into a global leader in food and beverages, with a portfolio of over 200 brands, including Pepsi, Lay's, and Gatorade.
11 Mar 2025
)
Bob Iger: Disney's Visionary CEO
Bob Iger is a legend in the entertainment industry, known for his visionary leadership and as one of the most influential CEOs in Disney's history.
10 Mar 2025
Ticker symbol
OYST
Country
🇺🇸 United States